Invention Grant
- Patent Title: Inhibitors of CYP17A1
-
Application No.: US14815686Application Date: 2015-07-31
-
Publication No.: US09611270B2Publication Date: 2017-04-04
- Inventor: Jeffrey Aube , Emily E. Scott , Charlie Fehl
- Applicant: University of Kansas
- Applicant Address: US KS Lawrence
- Assignee: UNIVERSITY OF KANSAS
- Current Assignee: UNIVERSITY OF KANSAS
- Current Assignee Address: US KS Lawrence
- Agency: Foley & Lardner LLP
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07J73/00 ; C07J71/00 ; C07J43/00 ; C07D401/04 ; C07J31/00 ; C07J21/00
Abstract:
Compounds according to formula I or II are provided. Such compounds are useful in treating cancers, such as leukemia, colon cancer, breast cancer, or prostate cancer by beneficially inhibiting CYP17A1. Pharmaceutical compositions and methods including the compounds are also provided.
Public/Granted literature
- US20160031929A1 INHIBITORS OF CYP17A1 Public/Granted day:2016-02-04
Information query
